Biofrontera AG BIFRF
OTC PK
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.19M | 4.35M | 4.16M | 4.16M | 3.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.19M | 4.35M | 4.16M | 4.16M | 3.45M |
| Cost of Revenue | 1.17M | 829.50K | 1.35M | 1.35M | 623.00K |
| Gross Profit | 5.02M | 3.52M | 2.81M | 2.81M | 2.82M |
| SG&A Expenses | 2.66M | 2.87M | 2.57M | 2.57M | 2.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.53M | 4.33M | 5.33M | 5.33M | 3.67M |
| Operating Income | 1.66M | 10.50K | -1.17M | -1.17M | -225.20K |
| Income Before Tax | 1.71M | 48.00K | -431.40K | -431.40K | -237.80K |
| Income Tax Expenses | 4.70K | -- | 1.20K | 1.20K | -- |
| Earnings from Continuing Operations | 1.71M | 48.00K | -432.60K | -432.60K | -237.80K |
| Earnings from Discontinued Operations | 2.17M | 2.53M | -- | -- | 951.30K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.88M | 2.57M | -432.60K | -432.60K | 713.50K |
| EBIT | 1.66M | 10.50K | -1.17M | -1.17M | -225.20K |
| EBITDA | 1.80M | 64.10K | -1.10M | -1.10M | -161.50K |
| EPS Basic | 0.64 | 0.42 | -0.07 | -0.07 | 0.12 |
| Normalized Basic EPS | 0.18 | 0.00 | -0.04 | -0.04 | -0.02 |
| EPS Diluted | 0.64 | 0.42 | -0.07 | -0.07 | 0.12 |
| Normalized Diluted EPS | 0.18 | 0.00 | -0.04 | -0.04 | -0.02 |
| Average Basic Shares Outstanding | 6.05M | 6.11M | 6.17M | 6.17M | 6.16M |
| Average Diluted Shares Outstanding | 6.05M | 6.11M | 6.17M | 6.17M | 6.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |